KNSA Competitors & Alternatives

Compare Kiniksa Pharmaceuticals Ltd with similar stocks in the same industry

Drug Manufacturers - Specialty & Generic

KNSA

Main Stock
$56.51
Tradestie Score
63
Market Cap
$2.86B
P/E Ratio
64.3
Revenue Growth
0.6%
Analyst Upside
+12.4%

Top Competitors

47 stocks in Drug Manufacturers - Specialty & Generic
Company Price Market Cap P/E Score Action
KRYS Krystal Biotech, Inc. Common Stock
$306.29
$5.20B 41.3 64 Compare
ALKS Alkermes Inc. plc
$37.48
$5.06B 42.6 63 Compare
CRNX Crinetics Pharmaceuticals, Inc.
$36.77
$3.92B - 58 Compare
MIRM Mirum Pharmaceuticals, Inc. Common Stock
$102.19
$3.67B - 54 Compare
LNTH Lantheus Holdings, Inc
$93.91
$3.51B 22.6 59 Compare
AMRX Amneal Pharmaceuticals, Inc. Class A Common Stock
$11.93
$3.26B 33.1 57 Compare
PBH Prestige Consumer Healthcare Inc.
$46.75
$3.12B 12.1 44 Compare
PRGO PERRIGO COMPANY PLC
$10.61
$3.10B - 56 Compare
INDV Indivior PLC Ordinary Shares
$36.76
$2.93B 19.4 60 Compare
HCM HUTCHMED (China) Limited American Depositary Shares
$12.51
$2.74B 4.8 52 Compare

Data updated: May 15, 2026 | Industry: Drug Manufacturers - Specialty & Generic (SIC 2834)

47 stocks in this industry